Amid the opioid crisis, urgent innovation in pain therapeutics is vital. This session addresses the opioid crisis head-on by exploring how the NIH, small biotech, biopharma, and VCs can rejuvenate CNS & pain innovation. The session will focus on pioneering strategies, boosting investment, and fostering public-private partnerships to fuel next-gen pain therapeutics and address this critical health need.